ICICI Life’s Q2 growth and margins improved, but a higher base, softer Ulip growth, regulatory proposals on commissions and potential share supply could weigh on its outlook and valuation.
Despite ICICI Life’s good Q2, investors must watch these risks
Published ·

Keep reading
Related stories




